Concepedia

Weiya Liu

WL

Statistics

Publications

10

Citations

459

H-Index

10

Active since

2005

Affiliations

University of Kansas Medical Center(Current)

University of Kansas

University of Michigan

University of Notre Dame

Weiya Liu is an author at University of Kansas Medical Center specializing in cancer pharmacology, medicinal chemistry, and pharmacology.

Publications per year

2005–2022

10

Publications

10

Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor

Anuj Khandelwal, Caitlin N. Kent, Maurie Balch et al. · Nature Communications · 2018 · 121 citations · Full text

, , +14

The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with <i>pan</i>-Hsp90 Inhibition

Sanket J. Mishra, Weiya Liu, Kristin Beebe et al. · Journal of Medicinal Chemistry · 2021 · 75 citations · Full text

, , +17

Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors

Bhaskar Reddy Kusuma, Anuj Khandelwal, Wen Gu et al. · Bioorganic & Medicinal Chemistry · 2014 · 56 citations · Full text

, , +6

Interaction of flavonoid, quercetin with organized molecular assemblies of nonionic surfactant

Weiya Liu, Rong Guo · Colloids and Surfaces A Physicochemical and Engineering Aspects · 2005 · 56 citations

, , +12

Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors

Katherine M. Byrd, Chitra Subramanian, Jacqueline Sanchez et al. · Chemistry - A European Journal · 2016 · 42 citations · Full text

, , +11

1–5 of 10